Literature DB >> 20957521

Improving venous thromboembolic disease prophylaxis in medical inpatients: a role for education and audit.

B D Kent1, P Nadarajan, N B Akasheh, I Sulaiman, S Karim, S Cooney, S J Lane, E D Moloney.   

Abstract

BACKGROUND: Venous thromboembolic disease (VTED) prophylaxis is a key strategy in reducing preventable deaths in medical inpatients. We assessed compliance with internationally published guidelines for VTED prophylaxis in at-risk medical patients before and 1 month after an educational intervention to enhance compliance with such guidelines.
RESULTS: One hundred and fifty patients were assessed on each occasion. Pre-intervention, VTED prophylaxis was prescribed in only 48% of at-risk cases. Compliance was best among patients under stroke services and worst for those under acute medical teams. Patients within specialist units were more likely to be prescribed prophylaxis than those in general wards (75 vs. 53%; p = 0.0019). Post-intervention, overall compliance improved to 63% (p = 0.041 for comparison). There was a significant improvement among general medical teams (48 vs. 75%; p = 0.001), and in general wards (52 vs. 74%; p = 0.003).
CONCLUSIONS: Thromboprophylaxis is under-prescribed in medical inpatients, but compliance with international guidelines can be significantly enhanced with targeted educational intervention.

Entities:  

Mesh:

Year:  2010        PMID: 20957521     DOI: 10.1007/s11845-010-0619-7

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  15 in total

1.  Audit-guided action can improve the compliance with thromboembolic prophylaxis prescribing to hospitalized, acutely ill older adults.

Authors:  S Timmons; C O'Callaghan; M O'Connor; D O'Mahony; C Twomey
Journal:  J Thromb Haemost       Date:  2005-09       Impact factor: 5.824

2.  Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients.

Authors:  Francesco Dentali; James D Douketis; Monica Gianni; Wendy Lim; Mark A Crowther
Journal:  Ann Intern Med       Date:  2007-02-20       Impact factor: 25.391

Review 3.  Comparing the costs, risks, and benefits of competing strategies for the primary prevention of venous thromboembolism.

Authors:  Jerry Avorn; Wolfgang C Winkelmayer
Journal:  Circulation       Date:  2004-12-14       Impact factor: 29.690

Review 4.  A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals.

Authors:  Rebecca Tooher; Philippa Middleton; Clarabelle Pham; Robert Fitridge; Siohban Rowe; Wendy Babidge; Guy Maddern
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

Review 5.  Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.

Authors:  Alexander T Cohen; Raza Alikhan; Juan I Arcelus; Jean-François Bergmann; Sylvia Haas; Geno J Merli; Alex C Spyropoulos; Victor F Tapson; Alexander G G Turpie
Journal:  Thromb Haemost       Date:  2005-10       Impact factor: 5.249

Review 6.  Venous thromboembolism after acute stroke.

Authors:  J Kelly; A Rudd; R Lewis; B J Hunt
Journal:  Stroke       Date:  2001-01       Impact factor: 7.914

7.  Electronic alerts to prevent venous thromboembolism among hospitalized patients.

Authors:  Nils Kucher; Sophia Koo; Rene Quiroz; Joshua M Cooper; Marilyn D Paterno; Boris Soukonnikov; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

8.  Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

9.  Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.

Authors:  Susan R Kahn; Akbar Panju; William Geerts; Graham F Pineo; Louis Desjardins; Alexander G G Turpie; Stanislav Glezer; Lehana Thabane; Rolf J Sebaldt
Journal:  Thromb Res       Date:  2006-03-03       Impact factor: 3.944

10.  The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.

Authors:  David G Sherman; Gregory W Albers; Christopher Bladin; Cesare Fieschi; Alberto A Gabbai; Carlos S Kase; William O'Riordan; Graham F Pineo
Journal:  Lancet       Date:  2007-04-21       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.